Back to Results

Chiron Real Estate Inc Preferred Series B (XRN_pb)

Featured in Small-Cap Stocks

Chiron Real Estate Inc. Preferred Series B (NYSE: XRN.PRB) is a preferred stock listing associated with Chiron Real Estate Inc., a Maryland-based real estate investment trust incorporated in 2011. The REIT focuses on net-lease medical properties, acquiring healthcare facilities and leasing them to physician groups as well as regional and national healthcare systems. As a preferred security, this listing represents an equity-linked instrument tied to the issuer rather than the company’s common stock.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-XRN.PRB
$32.27
27.1% Upside
Undervalued
—
—
—
Fair
July 15, 2026
July 31, 2026
—
7.9%
August 5, 2026
-32.9x
1.4x
3.4x
506.7 M
1.299 B
51.0%
93.0%
0.2
-711.7%
-499.0%
Send a message
Valuation • Fair Value

Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) Fair Value by Valuation Model

Compare the primary fair value estimate for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$32.27

Estimated upside of 27.1% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

$25.18

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$34.04

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

151.5 M

Current operating scale indicator.

Revenue Forecast

152.6 M

Forward revenue estimate.

EBITDA

91.401 M

Current operating profitability reference.

EBITDA Forecast

99 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-3.36

No elevated caution signal from this screen.

Altman Z-Score

0.2

Lower score that deserves closer risk review.

FCF / Net Income

-499.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 5, 2026

Days to Earnings

15

Dividend Payment Date

July 31, 2026

Ex-Dividend Date

July 15, 2026

Dividend Yield

7.9%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Cash

Distribution type as reported in the data.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

-711.7%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) Stock Forecast & Technical Outlook

Review Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) Stock FAQ

Quick answers about Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$32.27
Estimated upside 27.1%
Valuation Rating
Undervalued
Estimated upside of 27.1%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Fair
Current financial-health read

The current fair value estimate for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is $32.27. This implies an estimated upside of 27.1% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 27.1% versus the current market price.

An analyst price target for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is not currently available in the latest data file.

The current financial health read for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is August 5, 2026.

Based on the current data, dividend yield is 7.9%, ex-dividend date is July 15, 2026, payment date is July 31, 2026.

The current P/E ratio listed for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is -32.9x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Chiron Real Estate Inc Preferred Series B is 506.7 M.

The current enterprise value listed for Chiron Real Estate Inc Preferred Series B is 1.299 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Chiron Real Estate Inc Preferred Series B is NYSE-XRN.PRB, and the stock is listed on NYSE.

Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is listed on NYSE.

The current debt-to-total-capital ratio listed for Chiron Real Estate Inc Preferred Series B is 51.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Chiron Real Estate Inc Preferred Series B is 93.0%. Free float helps investors understand how much of the share base is available for public trading.

Similar Health Care REITs Stocks on NYSE View more

Welltower Inc (WELL) Welltower Inc (WELL)
Ventas Inc (VTR) Ventas Inc (VTR)
Healthpeak Properties Inc (DOC) Healthpeak Properties Inc (DOC)
Omega Healthcare Investors Inc (OHI) Omega Healthcare Investors Inc (OHI)
American Healthcare REIT Inc (AHR) American Healthcare REIT Inc (AHR)
Caretrust Inc (CTRE) Caretrust Inc (CTRE)
Alexandria Real Estate Equities Inc (ARE) Alexandria Real Estate Equities Inc (ARE)
Healthcare Realty Trust Incorporated (HR) Healthcare Realty Trust Incorporated (HR)
National Health Investors Inc (NHI) National Health Investors Inc (NHI)
Medical Properties Trust Inc (MPT) Medical Properties Trust Inc (MPT)
LTC Properties Inc (LTC) LTC Properties Inc (LTC)
Strawberry Fields Reit Inc (STRW) Strawberry Fields Reit Inc (STRW)
Universal Health Realty Income Trust (UHT) Universal Health Realty Income Trust (UHT)
Chiron Real Estate Inc (XRN) Chiron Real Estate Inc (XRN)
Chiron Real Estate Inc Preferred Series A (XRN_pa) Chiron Real Estate Inc Preferred Series A (XRN_pa)
Community Healthcare Trust Inc (CHCT) Community Healthcare Trust Inc (CHCT)